Structure and function of respiratory syncytial virus surface glycoproteins.
about
In Hot Pursuit of the First Vaccine Against Respiratory Syncytial VirusMeasles Virus Fusion Protein: Structure, Function and InhibitionStructural and Computational Biology in the Design of Immunogenic Vaccine AntigensDevelopment of next-generation respiratory virus vaccines through targeted modifications to viral immunomodulatory genesEmerging Vaccine TechnologiesVaccines for the 21st centuryCX3CR1 Is Expressed in Differentiated Human Ciliated Airway Cells and Co-Localizes with Respiratory Syncytial Virus on Cilia in a G Protein-Dependent MannerNative immunogold labeling of cell surface proteins and viral glycoproteins for cryo-electron microscopy and cryo-electron tomography applicationsReverse vaccinology 2.0: Human immunology instructs vaccine antigen designAnalysis of Human RSV Immunity at the Molecular Level: Learning from the Past and PresentProtein Crystallography in Vaccine Research and DevelopmentGS-5806 Inhibits a Broad Range of Respiratory Syncytial Virus Clinical Isolates by Blocking the Virus-Cell Fusion ProcessEmergence of ON1 genotype of human respiratory syncytial virus subgroup A in China between 2011 and 2015Discovery of imidazopyridine derivatives as highly potent respiratory syncytial virus fusion inhibitors.Characterization of a Prefusion-Specific Antibody That Recognizes a Quaternary, Cleavage-Dependent Epitope on the RSV Fusion GlycoproteinA Chimeric Pneumovirus Fusion Protein Carrying Neutralizing Epitopes of Both MPV and RSVThe interdependencies of viral load, the innate immune response, and clinical outcome in children presenting to the emergency department with respiratory syncytial virus-associated bronchiolitisMolecular mechanism of respiratory syncytial virus fusion inhibitors.Respiratory Syncytial Virus whole-genome sequencing identifies convergent evolution of sequence duplication in the C-terminus of the G gene.Vaccines against respiratory syncytial virus: The time has finally come.Evolution and Transmission of Respiratory Syncytial Group A (RSV-A) Viruses in Guangdong, China 2008-2015.A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum Adjuvant.Aptamers for respiratory syncytial virus detection.Gene sequence variability of the three surface proteins of human respiratory syncytial virus (HRSV) in TexasNeutralizing epitopes on the respiratory syncytial virus fusion glycoprotein.Therapeutic efficacy of a respiratory syncytial virus fusion inhibitorStructure-guided design of small-molecule therapeutics against RSV disease.Development and clinical applications of novel antibodies for prevention and treatment of respiratory syncytial virus infection.Aberrant T cell immunity triggered by human Respiratory Syncytial Virus and human Metapneumovirus infection.Neutralizing epitopes of RSV and palivizumab resistance in Japan.Modulation of Host Immunity by Human Respiratory Syncytial Virus Virulence Factors: A Synergic Inhibition of Both Innate and Adaptive Immunity.Dose Selection for an Adjuvanted Respiratory Syncytial Virus F Protein Vaccine for Older Adults Based on Humoral and Cellular Immune Responses.In silico analysis of amino acid variation in human respiratory syncytial virus: insights into immunodiagnosticsRSV glycoprotein and genomic RNA dynamics reveal filament assembly prior to the plasma membraneThe Complexity of Antibody Responses Elicited against the Respiratory Syncytial Virus Glycoproteins in Hospitalized Children Younger than 2 Years.The Heptad Repeat C Domain of the Respiratory Syncytial Virus Fusion Protein Plays a Key Role in Membrane Fusion.Vaccines for the Paramyxoviruses and Pneumoviruses: Successes, Candidates, and Hurdles.Molecular characteristics and successful management of a respiratory syncytial virus outbreak among pediatric patients with hemato-oncological disease.Efficacy of mucosal polyanhydride nanovaccine against respiratory syncytial virus infection in the neonatal calf.Structural basis for recognition of the central conserved region of RSV G by neutralizing human antibodies.
P2860
Q26748856-2FD45953-19F1-40D6-AD52-9C89F3D5C73BQ26750552-2390F445-1974-4FB8-959B-315DC3E48CA9Q26777382-01D5444E-72B9-4C13-995B-AB8F0A98DA50Q26782411-CADA4EAD-D631-4009-A275-87252BE8A255Q26783764-8BE6621F-86FB-4DDC-8EBE-954D94120508Q27007529-AED286BD-BF70-4F86-8EE7-FD646FA6B261Q27303940-CEE2A689-CB73-4F7A-A5A3-00C1127017DDQ27335433-928814B0-E84B-4A48-B088-1860B0A6AAD0Q28075274-EF923E2D-682A-4246-9ACA-A6A8A7306EA8Q28080556-B800B985-5674-447C-ACB6-AD0540653F40Q28087528-045ADC15-657C-4482-86A6-B4676E6FE98AQ30375062-8B008865-71DA-41AE-9A4C-43CC84C848A7Q33905939-900FEAA0-8B14-46BB-A750-CA18BFCE5CD3Q35559775-4721501E-1085-490F-87B8-30394C588813Q35687662-A273C337-9E5A-4C2D-A8F4-378E3D0B5C93Q36029158-1B52EDB6-2529-42F2-8062-94F3EFBAA15EQ36299483-BC94259E-ED6A-4CF0-A705-9742866BD315Q36517337-D3C5A70D-061D-4D7A-9478-F6A8010D9F7CQ36925097-D8BF580A-8A20-40EE-A3FE-7A4BE9FC5092Q37018347-E6AC35D7-B9B7-472E-96C6-D70A0EA9F58CQ37172480-12CD8E3F-A49F-4B07-B2C5-BC1CD4CFDF06Q37578458-5F8B4384-DBFF-4901-82DF-07AD2CB67FE9Q37654797-7B2B062A-F54A-4D9D-B237-AA5E439DF8DAQ38267482-0B38D040-A5D4-42FE-9665-805F4984E764Q38394731-56DC2056-BEB8-4106-A4F8-343F1D17A8CCQ38650711-E0C4D322-69A1-46BD-8729-6FD6B3902DFCQ38798541-61FE0274-1752-4276-9D7B-A5AA2A9389AAQ38969434-B5BD928C-02C4-4DE8-969A-A76670C39EB6Q39027049-439DF8A5-D7A4-42B2-89F4-3D534ACC39C0Q40059727-2CE7C000-C473-4057-8EBF-9F6C23AC001CQ40061831-FAB86EE1-9933-44AC-8484-03131C048D31Q40134310-C5C713A3-E651-4930-800F-8E28783F97F7Q41653256-0789AFA6-3290-4938-A43B-17F789998E00Q41689780-39750E68-2126-48A9-8E8D-7364DFEE5E09Q45323691-D8D43CFE-7E23-4EF4-9E2B-B8B9ACFCEEAEQ45323698-A099978B-DB9E-4368-A199-93F58FBFD001Q47555408-CD38EA40-2968-403B-A727-FC67DF8A0C6BQ49955766-44AE1C2B-D3C7-40DE-826E-A1DC00DEE42BQ50317606-79AE1141-E312-4875-AE09-68D69E1C1B95Q52365721-4078B820-5ACD-42A0-ADAE-3ECEE8EB2B11
P2860
Structure and function of respiratory syncytial virus surface glycoproteins.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Structure and function of respiratory syncytial virus surface glycoproteins.
@ast
Structure and function of respiratory syncytial virus surface glycoproteins.
@en
Structure and function of respiratory syncytial virus surface glycoproteins.
@nl
type
label
Structure and function of respiratory syncytial virus surface glycoproteins.
@ast
Structure and function of respiratory syncytial virus surface glycoproteins.
@en
Structure and function of respiratory syncytial virus surface glycoproteins.
@nl
prefLabel
Structure and function of respiratory syncytial virus surface glycoproteins.
@ast
Structure and function of respiratory syncytial virus surface glycoproteins.
@en
Structure and function of respiratory syncytial virus surface glycoproteins.
@nl
P2860
P1476
Structure and function of respiratory syncytial virus surface glycoproteins
@en
P2093
Mark E Peeples
William C Ray
P2860
P304
P356
10.1007/978-3-642-38919-1_4
P577
2013-01-01T00:00:00Z